Yuen KCJ - Search Results

1

Health Benefit Costs and Absenteeism Among Employed Patients With Acromegaly.

Yuen KCJ, Munoz KA, Brook RA, Beren IA, Whalen JD, Rohrbacker NJ, Ribeiro-Oliveira A Jr. Yuen KCJ, et al. Endocr Pract. 2021 Oct;27(10):1034-1039. doi: 10.1016/j.eprac.2021.04.412. Epub 2021 May 1. Endocr Pract. 2021. PMID: 33940182 Free article.

2

Pasireotide treatment does not modify hyperglycemic and corticosterone acute restraint stress responses in rats.

Ribeiro-Oliveira A Jr, Schweizer JROL, Amaral PHS, Bizzi MF, Silveira WCD, Espirito-Santo DTA, Zille G, Soares BS, Schmid HA, Yuen KCJ. Ribeiro-Oliveira A Jr, et al. Among authors: yuen kcj. Stress. 2018 Jul;21(4):370-375. doi: 10.1080/10253890.2018.1451838. Epub 2018 Apr 17. Stress. 2018. PMID: 29661114

3

Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic.

Yuen KCJ, Blevins LS Jr, Findling JW. Yuen KCJ, et al. Endocr Pract. 2020 Aug;26(8):915-922. doi: 10.4158/EP-2020-0308. Endocr Pract. 2020. PMID: 33471683 Free PMC article. Review.

4

Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers.

Urwyler SA, Lustenberger S, Drummond JR, Soares BS, Vogt DR, Ammer N, Yuen KCJ, Ribeiro-Oliveira A, Christ-Crain M. Urwyler SA, et al. Among authors: yuen kcj. Pituitary. 2021 Aug;24(4):555-563. doi: 10.1007/s11102-021-01132-9. Epub 2021 Feb 22. Pituitary. 2021. PMID: 33615399 Free PMC article.

5

Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care.

Ribeiro-Oliveira A Jr, Brook RA, Munoz KA, Beren IA, Whalen JD, Kleinman NL, Yuen KCJ. Ribeiro-Oliveira A Jr, et al. Among authors: yuen kcj. J Med Econ. 2021 Jan-Dec;24(1):432-439. doi: 10.1080/13696998.2021.1898968. J Med Econ. 2021. PMID: 33663311 Free article.

6

Oral Octreotide: A Review of Recent Clinical Trials and Practical Recommendations for Its Use in the Treatment of Patients With Acromegaly.

Yuen KCJ, Samson SL. Yuen KCJ, et al. Endocr Pract. 2022 Jun;28(6):637-645. doi: 10.1016/j.eprac.2022.04.009. Epub 2022 Apr 19. Endocr Pract. 2022. PMID: 35452815 Review.

7

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.

Tritos NA, Johannsson G, Korbonits M, Miller KK, Feldt-Rasmussen U, Yuen KC, King D, Mattsson AF, Jonsson PJ, Koltowska-Haggstrom M, Klibanski A, Biller BM. Tritos NA, et al. J Clin Endocrinol Metab. 2014 Jun;99(6):2018-29. doi: 10.1210/jc.2014-1013. Epub 2014 Apr 2. J Clin Endocrinol Metab. 2014. PMID: 24694339

8

Long-term efficacy and safety of pegvisomant therapy in acromegaly.

Yuen KC, Katznelson L. Yuen KC, et al. Endocr Pract. 2015 Mar;21(3):296-8. doi: 10.4158/EP14566.CO. Endocr Pract. 2015. PMID: 25667381 No abstract available.

9

Cost-Effectiveness and Efficacy of a Novel Combination Regimen in Acromegaly: A Prospective, Randomized Trial.

Bonert V, Mirocha J, Carmichael J, Yuen KCJ, Araki T, Melmed S. Bonert V, et al. Among authors: yuen kcj. J Clin Endocrinol Metab. 2020 Sep 1;105(9):dgaa444. doi: 10.1210/clinem/dgaa444. J Clin Endocrinol Metab. 2020. PMID: 32754748 Clinical Trial.

10

Effects of growth hormone receptor antagonism and somatostatin analog administration on quality of life in acromegaly.

Dichtel LE, Kimball A, Yuen KCJ, Woodmansee W, Haines MS, Guan QX, Swearingen B, Nachtigall LB, Tritos NA, Sharpless JL, Kaiser UB, Gerweck AV, Miller KK. Dichtel LE, et al. Among authors: yuen kcj. Clin Endocrinol (Oxf). 2021 Jan;94(1):58-65. doi: 10.1111/cen.14309. Epub 2020 Sep 11. Clin Endocrinol (Oxf). 2021. PMID: 32779234 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page